Improving access to care

Providing access to care for all is a significant and complex global challenge. At AstraZeneca, we focus primarily on helping people to afford their medication. In communities with limited healthcare infrastructure and significant unmet public health need, we partner with others to strengthen healthcare frameworks and capabilities and donate medication and supplies.

Patient assistance programs

For more than 35 years, we’ve worked hard to better understand the needs of patients and the health care system so that our assistance programs can make a difference.

We designed the AZ&Me Prescription Savings Programs to help qualifying people without insurance, those in Medicare Part D and those who receive their medications through participating health care facilities. In 2014, the AZ&Me Programs provided more than $670 million in savings to nearly 383,000 patients in the United States.

AstraZeneca is committed to helping people afford their medicines—whether they’re our medicines or those made by someone else. We participate in multi-manufacturer programs, such as the Partnership for Prescription Assistance, and support other charitable patient assistance organizations with the same goal—increasing access to medicines, as well as healthcare.

Drug donations

Since 2005, AstraZeneca has partnered with AmeriCares, an emergency response and global health organization, to donate and distribute more than $87 million (Wholesale Acquisition Cost, or WAC) in medicines to frontline health workers for people and communities in crisis domestically and around the world. In 2014, we provided product valued at $11,496,372 (WAC) to AmeriCares. AstraZeneca product donations to AmeriCares have been distributed in many countries around the world, including El Salvador, Tanzania and Cambodia.

AstraZeneca is committed to ensuring that patients receive appropriate medicine donations through reputable partners and that these donations are of the highest quality. To that end, AstraZeneca aligns our product donations with both the World Health Organization (WHO) “Guidelines for Medicine Donations”, as revised, and the Partnership for Quality Medical Donations (PQMD) “Guidelines for Quality Medical Product Donations”, as revised.

Global programs

 

 

Healthy Heart Africa: Healthy Heart Africa is a program launched by AZ 
in October 2014. It aims to support local health systems in Africa by increasing awareness of the symptoms and risks of hypertension and by offering education, screening, reduced-cost treatment and control.

Cambodia Breast Cancer Initiative: Breast cancer related mortality remains devastatingly high in the developing world due to limited awareness of self-screening practices, low access to diagnostic technology and cost of oncology medicines. The Cambodia Breast Cancer Initiative is an ongoing partnership between AstraZeneca, AmeriCares and Sihanouk Center of Hope (SHCH) Hospital in Phnom Pen, Cambodia to strengthen existing treatment services while expanding in scale to reach additional patients. AstraZeneca provides free medicine to postmenopausal breast cancer patients in the Center of HOPE’s treatment cohort and supports the education of Cambodian women about the importance of early detection and prompt care-seeking.

Breast Cancer in Africa: Breast cancer is a leading cause of cancer death among women in South Africa. AstraZeneca is collaborating with a group of local organizations to help raise breast cancer awareness, increase early diagnosis, and improve access to treatment and effective support networks. More than 1.6 million women have been reached by trained volunteers across the country. South Africa’s Foundation for Professional Development is also providing accredited courses in cancer diagnosis, treatment and care to healthcare professionals.

AstraZeneca is committed to ensuring that patients receive appropriate medicine donations through reputable partners and that these donations are of the highest quality. To that end, AstraZeneca aligns our product donations with both the World Health Organization (WHO) “Guidelines for Medicine Donations”, as revised, and the Partnership for Quality Medical Donations (PQMD) “Guidelines for Quality Medical Product Donations”, as revised.